Diagnos Stock Odds of Future Stock Price Finishing Over 0.31
| ADK Stock | CAD 0.31 0.01 3.13% |
Diagnos |
Diagnos Target Price Odds to finish over 0.31
The tendency of Diagnos Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.31 | 90 days | 0.31 | about 72.36 |
Based on a normal probability distribution, the odds of Diagnos to move above the current price in 90 days from now is about 72.36 (This Diagnos probability density function shows the probability of Diagnos Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Diagnos has a beta of -0.22. This suggests as returns on the benchmark increase, returns on holding Diagnos are expected to decrease at a much lower rate. During a bear market, however, Diagnos is likely to outperform the market. Additionally Diagnos has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Diagnos Price Density |
| Price |
Predictive Modules for Diagnos
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diagnos. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Diagnos Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Diagnos is not an exception. The market had few large corrections towards the Diagnos' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Diagnos, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Diagnos within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | -0.22 | |
σ | Overall volatility | 0.03 | |
Ir | Information ratio | -0.08 |
Diagnos Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Diagnos for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Diagnos can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Diagnos generated a negative expected return over the last 90 days | |
| Diagnos has some characteristics of a very speculative penny stock | |
| Diagnos has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 170.16 K. Net Loss for the year was (3.12 M) with loss before overhead, payroll, taxes, and interest of (306.77 K). | |
| Diagnos has accumulated about 97.5 K in cash with (2.41 M) of positive cash flow from operations. | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Suraksha Diagnostic shares list at 1 percent discount over IPO price - The Economic Times |
Diagnos Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Diagnos Stock often depends not only on the future outlook of the current and potential Diagnos' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Diagnos' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 72.8 M | |
| Cash And Short Term Investments | 219 K |
Diagnos Technical Analysis
Diagnos' future price can be derived by breaking down and analyzing its technical indicators over time. Diagnos Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Diagnos. In general, you should focus on analyzing Diagnos Stock price patterns and their correlations with different microeconomic environments and drivers.
Diagnos Predictive Forecast Models
Diagnos' time-series forecasting models is one of many Diagnos' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Diagnos' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Diagnos
Checking the ongoing alerts about Diagnos for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Diagnos help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Diagnos generated a negative expected return over the last 90 days | |
| Diagnos has some characteristics of a very speculative penny stock | |
| Diagnos has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 170.16 K. Net Loss for the year was (3.12 M) with loss before overhead, payroll, taxes, and interest of (306.77 K). | |
| Diagnos has accumulated about 97.5 K in cash with (2.41 M) of positive cash flow from operations. | |
| Roughly 14.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Suraksha Diagnostic shares list at 1 percent discount over IPO price - The Economic Times |
Additional Tools for Diagnos Stock Analysis
When running Diagnos' price analysis, check to measure Diagnos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnos is operating at the current time. Most of Diagnos' value examination focuses on studying past and present price action to predict the probability of Diagnos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnos' price. Additionally, you may evaluate how the addition of Diagnos to your portfolios can decrease your overall portfolio volatility.